Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
wodenokoto
35 days ago
|
parent
|
context
|
favorite
| on:
Goldman Sachs asks in biotech Report: Is curing pa...
That is not the alternative to curing disease that is being proposed. The choice is between healing for good or keep on continued medication.
Or more bluntly: sell a product or sell a subscription
anonymouskimmer
24 days ago
[–]
The point I was trying to make is that most pharma companies have many products for many disorders and diseases. Curing one of those diseases will make a few life-long patients for some of your non-curing treatments.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search:
Or more bluntly: sell a product or sell a subscription